ATE194660T1 - Veraendertes gen bei menschlichem colorektalem- krebs - Google Patents

Veraendertes gen bei menschlichem colorektalem- krebs

Info

Publication number
ATE194660T1
ATE194660T1 AT92905276T AT92905276T ATE194660T1 AT E194660 T1 ATE194660 T1 AT E194660T1 AT 92905276 T AT92905276 T AT 92905276T AT 92905276 T AT92905276 T AT 92905276T AT E194660 T1 ATE194660 T1 AT E194660T1
Authority
AT
Austria
Prior art keywords
mcc
colorectal cancer
human colorectal
altered gene
human
Prior art date
Application number
AT92905276T
Other languages
English (en)
Inventor
Bert Vogelstein
Kenneth W Kinzler
Raymond L White
Yusuke Nakamura
Original Assignee
Univ Johns Hopkins
Univ Utah
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Univ Utah, Japan Found Cancer filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE194660T1 publication Critical patent/ATE194660T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92905276T 1991-03-13 1992-01-16 Veraendertes gen bei menschlichem colorektalem- krebs ATE194660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,611 US5330892A (en) 1991-03-13 1991-03-13 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
PCT/US1992/000377 WO1992016656A1 (en) 1991-03-13 1992-01-16 Gene mutated in colorectal cancer of humans

Publications (1)

Publication Number Publication Date
ATE194660T1 true ATE194660T1 (de) 2000-07-15

Family

ID=24691103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92905276T ATE194660T1 (de) 1991-03-13 1992-01-16 Veraendertes gen bei menschlichem colorektalem- krebs

Country Status (11)

Country Link
US (5) US5330892A (de)
EP (1) EP0580596B1 (de)
JP (1) JP3501802B2 (de)
AT (1) ATE194660T1 (de)
AU (1) AU664834B2 (de)
CA (1) CA2105876A1 (de)
DE (1) DE69231245T2 (de)
DK (1) DK0580596T3 (de)
ES (1) ES2148171T3 (de)
GR (1) GR3034446T3 (de)
WO (1) WO1992016656A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
EP0672181B1 (de) 1992-04-01 2003-11-05 The Johns Hopkins University School Of Medicine Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
US7326778B1 (en) * 1993-05-05 2008-02-05 The John Hopkins University Mutator gene and hereditary non-polyposis colorectal cancer
JPH09501045A (ja) * 1993-05-26 1997-02-04 ザ・ジョーンズ・ホプキンス・ユニバーシティ Ｄｃｃ遺伝子産物特異的抗体
US5962220A (en) * 1993-10-26 1999-10-05 Thomas Jefferson University Compositions that specifically bind to colorectal cells and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
US5891629A (en) * 1995-09-28 1999-04-06 Ambion, Inc. Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6242212B1 (en) * 1996-02-09 2001-06-05 Thomas Jefferson University Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US20020064792A1 (en) * 1997-11-13 2002-05-30 Lincoln Stephen E. Database for storage and analysis of full-length sequences
US6897018B1 (en) * 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
AU5128799A (en) * 1998-07-24 2000-02-14 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pb 39, a gene dysregulated in prostate cancer, and uses thereof
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
DE60028732T2 (de) 1999-02-25 2007-06-14 Exact Sciences Corp., Maynard Verfahren zur erhaltung der dns-integrität
CA2366778C (en) * 1999-04-09 2008-07-22 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
WO2001042781A2 (en) * 1999-12-07 2001-06-14 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
EP2949762B1 (de) 2000-03-27 2018-05-09 Thomas Jefferson University Zusammensetzungen zur behandlung von magen- und speiseröhrenkrebszellen
WO2002016605A1 (fr) * 2000-08-25 2002-02-28 Fujirebio Inc. Procede de protection d'informations personnelles
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
US7776524B2 (en) * 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
US7767468B2 (en) * 2003-11-05 2010-08-03 Exact Sciences Corporation Repetitive affinity separation and uses therefor
CA2553540A1 (en) * 2004-01-23 2005-08-04 Garvan Institute Of Medical Research Methods of diagnosing colorectal cancer and reagents therefor
US20080241827A1 (en) * 2004-05-10 2008-10-02 Exact Sciences Corporation Methods For Detecting A Mutant Nucleic Acid
WO2005113769A1 (en) * 2004-05-14 2005-12-01 Exact Sciences Corporation Method for stabilizing biological samples for nucleic acid analysis
US7981607B2 (en) * 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) * 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
EP3495506B1 (de) 2013-12-11 2023-07-12 AccuraGen Holdings Limited Verfahren zum nachweis seltener sequenzvarianten
US11859246B2 (en) 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
JP7008016B2 (ja) 2015-10-09 2022-01-25 アキュラジェン ホールディングス リミテッド 増幅産生物の富化のための方法および組成物
US11427866B2 (en) 2016-05-16 2022-08-30 Accuragen Holdings Limited Method of improved sequencing by strand identification
JP6966052B2 (ja) 2016-08-15 2021-11-10 アキュラーゲン ホールディングス リミテッド 稀な配列変異体を検出するための組成物および方法
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
US12049665B2 (en) 2018-06-12 2024-07-30 Accuragen Holdings Limited Methods and compositions for forming ligation products
CN115963268B (zh) * 2023-02-14 2023-09-19 浙江大学 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
CA2001815C (en) * 1988-10-31 2002-09-03 Wen-Hwa Lee Products and methods for controlling the suppression of the neoplastic phenotype
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
US5411860A (en) * 1992-04-07 1995-05-02 The Johns Hopkins University Amplification of human MDM2 gene in human tumors

Also Published As

Publication number Publication date
GR3034446T3 (en) 2000-12-29
US5576422A (en) 1996-11-19
US5830676A (en) 1998-11-03
AU1330292A (en) 1992-10-21
AU664834B2 (en) 1995-12-07
JP3501802B2 (ja) 2004-03-02
US5571905A (en) 1996-11-05
DE69231245T2 (de) 2001-02-01
US5330892A (en) 1994-07-19
DE69231245D1 (de) 2000-08-17
ES2148171T3 (es) 2000-10-16
WO1992016656A1 (en) 1992-10-01
EP0580596B1 (de) 2000-07-12
US5693536A (en) 1997-12-02
DK0580596T3 (da) 2000-10-30
EP0580596A1 (de) 1994-02-02
JPH06509701A (ja) 1994-11-02
CA2105876A1 (en) 1992-09-14

Similar Documents

Publication Publication Date Title
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
DE69231734D1 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
ATE238553T1 (de) Krebsbehandlung
DK0507852T3 (da) Gen deleteret hos mennesker med kolorektal cancer
EP0390323A3 (de) Nachweis des Ausfalls des Wildtyps des p53-Gens
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
MacKie Skin cancer
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
ATE291614T1 (de) Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
HUP0302332A2 (hu) Génkimutatási eljárás ErbB-antagonistával végzett rákterápiára adott hatékony reakció valószínûségének növelésére
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
MX9708401A (es) Genes reguladores de la cromatina.
EP1767636A3 (de) Verbindungen zur Immonotherapie und Diagnose von Dickdarmkrebs und Verfahren zu Ihrer Anwendung
AU7868300A (en) Prostate cancer marker proteins
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
DE69721731D1 (de) Immortalisierte menschliche prostata-epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
Vazquez-Mazariego et al. Cytogenetic study of neuroendocrine carcinoma of Merkel cells
SADAHIRO et al. A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE
SU668725A1 (ru) Сито
SU700723A2 (ru) Косозуба зубчата передача
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
ATE345503T1 (de) Krebsdiagnoseverfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee